{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:39:07Z","timestamp":1781285947643,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112-189"],"award-info":[{"award-number":["V112-189"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-076"],"award-info":[{"award-number":["V113C-076"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabres.2025.112912","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:13:10Z","timestamp":1758575590000},"page":"112912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Psoriasis and risk of diabetic retinopathy in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"229","author":[{"given":"Ming-Pei","family":"Yueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Kai","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Cyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harn-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-En","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112912_b0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.diabres.2025.112912_b0010","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabres.2025.112912_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2025.112912_b0020","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4103\/1673-5374.355743","article-title":"Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy","volume":"18","author":"Tang","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.diabres.2025.112912_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","article-title":"The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the Global Burden of Disease Study 2017","volume":"84","author":"Mehrmal","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-4632.2011.05424.x","article-title":"Ocular findings in patients with psoriasis","volume":"52","author":"Kilic","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3892\/etm.2021.10413","article-title":"Psoriasis beyond the skin: ophthalmological changes (Review)","volume":"22","author":"Constantin","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.diabres.2025.112912_b0045","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jaad.2019.05.067","article-title":"Peripheral retinal vascular leakage in moderate to severe psoriasis: a pilot study","volume":"85","author":"Enos","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0050","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2018.1476556","article-title":"Metabolic syndrome may exacerbate macular and retinal damage in psoriasis vulgaris","author":"Korkmaz","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.diabres.2025.112912_b0055","doi-asserted-by":"crossref","first-page":"16720","DOI":"10.1038\/s41598-022-20307-3","article-title":"Retinal vascular assessment in psoriatic patients with and without metabolic syndrome using optical coherence tomography angiography","volume":"12","author":"Tolba","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2025.112912_b0060","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/1346-8138.16062","article-title":"Risk of retinal diseases in patients with psoriasis: a population\u2010based cohort study in Taiwan","volume":"48","author":"Dai","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ajo.2024.08.033","article-title":"Psoriasis as a predictor of neovascular age-related macular degeneration in type 2 diabetes mellitus: a nationwide Cohort study","volume":"269","author":"Lee","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.diabres.2025.112912_b0070","doi-asserted-by":"crossref","unstructured":"Lee MY, Han K, Koo HYR, Yu DS, Lee YB. Psoriasis increases retinal vein occlusion risk in diabetic patients: a nationwide population-based study. Retina. 2022:10.1097. doi: 10.1097\/IAE.0000000000003916.","DOI":"10.1097\/IAE.0000000000003916"},{"key":"10.1016\/j.diabres.2025.112912_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8035","article-title":"Association of cataract surgery with risk of diabetic retinopathy among Asian participants in the singapore epidemiology of eye diseases study","volume":"3","author":"Tham","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabres.2025.112912_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202347","article-title":"Development of diabetic retinopathy after cataract surgery","volume":"13","author":"Jeng","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2025.112912_b0085","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ophtha.2009.03.003","article-title":"Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery","volume":"116","author":"Hong","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.diabres.2025.112912_b0090","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.112912_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112912_b0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7861\/clinmedicine.10-5-505","article-title":"Microvascular complications: pathophysiology and management","volume":"10","author":"Vithian","year":"2010","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.diabres.2025.112912_b0105","doi-asserted-by":"crossref","unstructured":"dell\u2032 Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C. Vitreous mediators in retinal hypoxic diseases. Mediators of Inflammation. 2013;2013:935301. doi: 10.1155\/2013\/935301.","DOI":"10.1155\/2013\/935301"},{"key":"10.1016\/j.diabres.2025.112912_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9402198","article-title":"Association between aqueous cytokines and diabetic retinopathy stage","volume":"2017","author":"Wu","year":"2017","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.diabres.2025.112912_b0115","article-title":"Interleukin-17A in diabetic retinopathy: the crosstalk of inflammation and angiogenesis","author":"Li","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.diabres.2025.112912_b0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.diabres.2025.112912_b0125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.dsx.2010.05.021","article-title":"Impact of metabolic syndrome and its severity on microvascular complications in type 2 diabetes","volume":"4","author":"Hermans","year":"2010","journal-title":"Diabet Metabol Syndrome: Clin Res Rev"},{"key":"10.1016\/j.diabres.2025.112912_b0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/24755303231199995","article-title":"Serum adiponectin levels as an independent marker of severity of psoriasis: a cross-sectional analysis","volume":"8","author":"Kaushik","year":"2023","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"10.1016\/j.diabres.2025.112912_b0145","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s40123-023-00702-3","article-title":"Potential protective function of adiponectin in diabetic retinopathy","volume":"12","author":"Deng","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.diabres.2025.112912_b0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.13038","article-title":"Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.diabres.2025.112912_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/db14-0312","article-title":"Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice","volume":"64","author":"Lian","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112912_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2013.11.003","article-title":"Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic \u03b2 cells and adipocytes","volume":"28","author":"Tao","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112912_b0165","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2147\/JIR.S358594","article-title":"Adiponectin ameliorates hyperglycemia-induced retinal endothelial dysfunction, highlighting pathways, regulators, and networks","volume":"15","author":"Bushra","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.diabres.2025.112912_b0170","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.dsx.2018.11.061","article-title":"Inflammatory markers and control of type 2 diabetes mellitus","volume":"13","author":"Elimam","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2025.112912_b0175","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.diabres.2025.112912_b0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, andfrailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.diabres.2025.112912_b0185","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s13555-025-01423-0","article-title":"Biologics for the treatment of moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis","volume":"15","author":"Lebwohl","year":"2025","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.diabres.2025.112912_b0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.diabres.2025.112912_b0195","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/jdi.13895","article-title":"Current status of diabetic kidney disease and latest trends in management","volume":"13","author":"Kim","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2025.112912_b0200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272500926X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272500926X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:53:10Z","timestamp":1777510390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272500926X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"alternative-id":["S016882272500926X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112912","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis and risk of diabetic retinopathy in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112912"}}